MILab’s preclinical imaging annual sales grows again by nearly 50%

April 6th 2018

MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continue on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close tot 50%.

Read the article here